A randomized multicentre phase II trial comparing adjuvant therapy in patients with Interferon alpha-2b and 5-FU alone or in combination with either external radiation treatment and cisplatin (CapRI) or radiation alone regarding event-free survival - CapRI-2

Saved in:

Bibliographic Details
Other Authors:	Märten, Angela (Other) , Schmidt, Jan (Other) , Ose, Jennifer (Other) , Harig, Sabine (Other) , Abel, Ulrich (Other) , Münter, Marc (Other) , Jäger, Dirk (Other) , Friess, Helmut (Other) , Mayerle, Julia (Other) , Adler, Guido (Other) , Seufferlein, Thomas (Other) , Greß, Thomas (Other) , Schmid, Roland (Other) , Büchler, Markus W. (Other)
Format:	Article (Journal)
Language:	English
Published:	2009
In:	BMC cancer Year: 2009, Volume: 9
ISSN:	1471-2407
DOI:	10.1186/1471-2407-9-160
Online Access:	Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1186/1471-2407-9-160 Verlag, Volltext: http://www.biomedcentral.com/1471-2407/9/160
Author Notes:	Angela Märten, Jan Schmidt, Jennifer Ose, Sabine Harig, Ulrich Abel, Marc W Münter, Dirk Jäger, Helmut Friess, Julia Mayerle, Guido Adler, Thomas Seufferlein, Thomas Gress, Roland Schmid and Markus W Büchler

Similar Items